Delivery Order SPE2DR25D1205-SPE2DR26F1AA5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,214.60 to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Yuvafem 10 microgram vaginal inserts (18 count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 13, 2026. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. AmerisourceBergen Drug Corp is...
- The Defense Logistics Agency awarded a $2,496.87 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18 units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by October 28, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a $2,660.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for Yuvafem 10 mcg vaginal inserts (18 units). This is a non-set-aside competitive award with an ultimate completion date of May 9, 2025, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's existing contract vehicle with DLA. This award falls under...
- The Defense Logistics Agency awarded a delivery order valued at $3,607.76 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18 count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price contract, classified as a non-set-aside award, will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,004.41 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 MCG Vaginal Insert (8 count). The award, issued on September 12, 2025, represents a firm fixed-price contract with an ultimate completion date of September 15, 2025. This is a non-set-aside competitive award, and performance will occur at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,563.86 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 mcg vaginal inserts (18-count units). This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 4, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $3,946.09 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 21, 2025. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,928.27 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on December 5, 2025, with completion scheduled for December 8, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,752.65 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (8-count package) on October 30, 2025, with an ultimate completion date of October 31, 2025. This competitively awarded, firm fixed-price delivery order was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child contract under a larger procurement vehicle. No set-aside designation was used for this...
- The Defense Logistics Agency awarded a delivery order valued at $1,719.12 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg Vaginal Insert (18-count) on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The awardee is a subsidiary of parent company Cencora, Inc. (doing business as...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F1AA5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,632.18 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 mcg vaginal inserts (18 units). This contract was competitively awarded on January 15, 2026, with an ultimate completion date of January 16, 2026, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award utilized firm fixed-price pricing with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds the primary IDC vehicle with DLA and serves as a critical pharmaceutical distributor for federal military healthcare systems. These IDCs enable AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military treatment facilities and other federal healthcare institutions globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 1/14/26 |